Botulinum Toxin Market Share, Trends, Analysis, Regional Outlook and Future Insights | MRFR
Botulinum
Toxin Market Highlights
The
botulinum toxin market size is projected to reach USD 6.5 billion by 2030, at a
CAGR of 11.80% from 2022 to 2030.
Botulinum
toxin is known as one of the most poisonous biological substances. It is a
neurotoxin produced by the bacterium Clostridium botulinum. There are seven
distinct forms of botulinum toxin, types A–G. Four of these (types A, B, E, and
rarely F) cause human botulism. Botulinum toxin A and B are used for
therapeutic and aesthetic procedures. The increasing cases of spasticity,
cervical dystonia and chronic migraine, surge in demand for facial aesthetic,
and rising number of product launches and approvals by key players are likely
to drive the growth of the global botulinum toxin market
during the forecast period.
Segment
Analysis
The
Global Botulinum Toxin Market, by type, has been segmented into botulinum toxin
type A and B. Rising
adoption of botulinum toxin in aesthetic procedures as compared to tissue
fillers and increasing product approvals by regulatory authorities is
anticipated to drive the growth of this segment during the forecast period. As
per the Plastic Surgery Statistics Report published in 2018 by the American
Society of Plastic Surgeons, the number of cosmetic minimally invasive
procedures involving the use of botulinum toxin type A was 7.43 million in
2018, whereas the processes involving the use of soft tissue fillers were 2.67
million in 2018 in the US.
The Global
Botulinum Toxin Market, by application segment, has been segmented into
therapeutic application and aesthetics
applications.
The
therapeutics segment has been further divided into a chronic migraine,
spasticity, cervical dystonia, overactive bladder, blepharospasm, and others.
Based
on end-user, the global botulinum toxin market has been classified into
dermatology centers, hospitals & clinics, and others.
Market Players
The Global
Botulinum Toxin Market Players - Allergan PLC, Merz Pharma GmbH & Co KGaA,
Galderma S.A., Daewoong Pharmaceutical Co., Ltd, Ipsen Pharma, US WorldMeds,
LLC. (Solstice Neurosciences, LLC), Evolus, Inc., Hugel, Inc, Medytox, Revance
Therapeutics, Inc., and others.
Regional
Analysis
The
Botulinum toxin research
international Market, based on region, has been
divided into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa.
The Americas
is likely to hold the largest share of the global botulinum toxin market. The
Americas is divided into North America and Latin America. North America has
been further subdivided into the US and Canada. The increasing product
approvals, rising cases of spasticity, and the presence of major manufacturers
such as US WorldMeds, LLC., Evolus, Inc., Hugel, Inc., and Revance
Therapeutics, Inc. in the region is expected to drive the market growth in this
region.
Europe
established substantial growth in the market owing to rising botulinum toxin
procedures and the presence of developed economies such as Germany, the UK, and
France. Additionally, there is an increasing demand for minimally invasive
cosmetic procedures to enhance the young-looking appearance, which in turn is
driving the growth of the market in this region.
Asia-Pacific
is estimated to be the fastest-growing region in the global market due to the
growing geriatric population, rising per capita disposable income, developing
healthcare infrastructure, medical tourism, booming entertainment industry, and
rising investments by major players in the regional market are likely to drive
the growth of the market.
The botulinum toxin market report in the Middle East & Africa is expected to grow due to the rising
awareness about botulinum toxin coupled with developing healthcare
infrastructure and rising demand for products from countries like Saudi Arabia
and UAE.
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment